DFE Pharma
Anilkumar Gandhi serves as the Director of the C2F Centre of Excellence within the Global Business Unit at DFE Pharma since January 2021, where responsibilities include strategizing for growth and integrating advanced technologies in Continuous Manufacturing while connecting with customers globally. Prior to this role, Anilkumar provided consultancy services focusing on novel drug delivery systems and innovative dosage formats from March 2020 to January 2021 and served as an Associate Professor at Vivekanand Education Society's College of Pharmacy. Anilkumar has a rich background in research and development leadership across multiple organizations, including Lyrus Life Sciences and Lotus Pharmaceutical Ltd., emphasizing product development and innovation in pharmaceutical formulations. Anilkumar holds a PhD and a Master's degree in Pharmacy from the Institute of Chemical Technology.
This person is not in any offices
DFE Pharma
2 followers
DFE Pharma is a global leader in pharmaceutical excipient solutions. We develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With over a century of experience and over 400+ people worldwide in over 100 countries serving over 5,000 customers, DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives. We are driven by our purpose your medicines, our solutions. Moving to a healthier world. Learn more at www.dfepharma.com